August 15, 2023
National Institute on Drug Abuse (NIDA)
This is a Notice of Correction to the Key Dates information in PAR-20-274 New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 - Clinical Trial Optional)
The following section of PAR-20-274 has been corrected:
Key Dates
Currently, it reads:
Posted Date
August 28, 2020
Open Date (Earliest Submission Date)
October 18, 2020
Letter of Intent Due Date(s)
Not applicable
Application Due Date(s)
Only accepting applications for the AIDS Application Due Dates listed below.
AIDS Application Due Date(s)
November 18, 2020, August 11, 2021, November 18, 2021, August 11, 2022, November 18, 2022, August 11, 2023
Scientific Merit Review
March 2021,November 2021, March 2022, November 2022, March 2023, November 2023
Advisory Council Review
May 2021, January 2022, May 2022, January 2023, May 2023, January 2024
Earliest Start Date
July 2021, March 2022, July 2022, March 2023, July 2023, March 2024
Expiration Date
New Date July 19, 2023 per issuance of RFA-DA-25-020. (Original Expiration Date: August 12, 2023)
Key Dates
Revised to read (in bold italics):
Posted Date
August 28, 2020
Open Date (Earliest Submission Date)
October 18, 2020
Letter of Intent Due Date(s)
Not applicable
Application Due Date(s)
Only accepting applications for the AIDS Application Due Dates listed below.
AIDS Application Due Date(s)
November 18, 2020, August 11, 2021, November 18, 2021, August 11, 2022, November 18, 2022, September 15, 2023
Scientific Merit Review
March 2021,November 2021, March 2022, November 2022, March 2023, November 2023
Advisory Council Review
May 2021, January 2022, May 2022, January 2023, May 2023, January 2024
Earliest Start Date
July 2021, March 2022, July 2022, March 2023, July 2023, March 2024
Expiration Date
New Date September 16, 2023
All other aspects of PAR-20-274 remain unchanged.
Minnjuan Flournoy Floyd, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6474
Email: [email protected]